TEM
Tempus AI, Inc. NASDAQ Listed Jun 14, 2024$49.43
Mkt Cap $8.6B
52w Low $41.73
12.3% of range
52w High $104.32
50d MA $50.59
200d MA $67.08
P/E (TTM)
-39.0x
EV/EBITDA
-47.2x
P/B
19.5x
Debt/Equity
1.7x
ROE
-49.9%
P/FCF
-43.0x
RSI (14)
—
ATR (14)
—
Beta
4.90
50d MA
$50.59
200d MA
$67.08
Avg Volume
5.4M
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaborations agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.
600 West Chicago Avenue · Chicago, IL 60654 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | -0.21 | -0.13 | +38.1% | 54.07 | -6.0% | -1.1% | -7.5% | — | — | — | — |
| Feb 24, 2026 | AMC | -0.04 | -0.04 | +8.7% | 57.95 | -1.5% | -7.3% | +3.2% | -3.9% | +0.1% | -3.6% | — |
| Nov 4, 2025 | AMC | -0.17 | -0.11 | +36.2% | 84.49 | -2.7% | -2.6% | -12.4% | -0.7% | +0.3% | -0.3% | — |
| Aug 8, 2025 | AMC | -0.23 | -0.22 | +4.3% | 60.87 | -1.4% | -0.1% | +9.1% | +5.0% | +2.8% | +3.1% | — |
| May 6, 2025 | AMC | -0.26 | -0.24 | +7.7% | 52.19 | -0.1% | +12.6% | +11.0% | -5.9% | +2.2% | +9.9% | — |
| Feb 24, 2025 | AMC | -0.15 | -0.18 | -20.0% | 69.57 | -15.9% | -15.0% | +5.3% | -11.2% | +1.6% | -9.3% | — |
| Nov 4, 2024 | AMC | -0.27 | -0.25 | +6.1% | 49.50 | -1.4% | -10.1% | +28.0% | -0.3% | +29.9% | +5.2% | — |
| Aug 6, 2024 | AMC | -0.59 | -0.63 | -6.8% | 40.65 | -1.8% | -4.5% | +0.3% | -0.5% | -0.2% | +10.3% | — |
| Jun 17, 2024 | AMC | — | -0.38 | — | 36.48 | +1.4% | -16.9% | -10.1% | +5.1% | -11.6% | -1.4% | — |
| Dec 31, 2023 | AMC | — | -0.30 | — | — | — | — | — | — | — | — | — |
| Sep 30, 2023 | AMC | — | -0.31 | — | — | — | — | — | — | — | — | — |
| Jun 30, 2023 | AMC | — | -0.33 | — | — | — | — | — | — | — | — | — |
| Mar 31, 2023 | AMC | — | -0.32 | — | — | — | — | — | — | — | — | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 | Guggenheim | Maintains | Buy → Buy | — | $42.62 | $42.36 | -0.6% | -0.6% | +6.7% | +4.0% | +0.8% | -0.2% |
| Mar 11 | Needham | Maintains | Buy → Buy | — | $50.90 | $51.54 | +1.3% | +3.5% | -6.0% | +0.9% | +1.8% | -0.1% |
| Mar 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $52.26 | $50.89 | -2.6% | +0.1% | -2.7% | +3.5% | -6.0% | +0.9% |
| Mar 3 | Morgan Stanley | Maintains | Overweight → Overweight | — | $53.31 | $51.13 | -4.1% | -3.6% | -0.2% | +3.4% | -1.5% | +0.1% |
| Feb 25 | Needham | Maintains | Buy → Buy | — | $57.95 | $57.08 | -1.5% | -7.3% | +3.2% | -3.9% | +0.1% | -3.6% |
| Feb 25 | JP Morgan | Maintains | Neutral → Neutral | — | $57.95 | $57.08 | -1.5% | -7.3% | +3.2% | -3.9% | +0.1% | -3.6% |
| Feb 25 | BTIG | Maintains | Buy → Buy | — | $57.95 | $57.08 | -1.5% | -7.3% | +3.2% | -3.9% | +0.1% | -3.6% |
| Dec 22 | Canaccord Genuity | Maintains | Buy → Buy | — | $64.46 | $66.36 | +2.9% | +2.3% | -1.8% | -0.7% | -2.4% | -2.0% |
| Dec 15 | JP Morgan | Maintains | Neutral → Neutral | — | $70.61 | $70.53 | -0.1% | -2.7% | -0.8% | -5.1% | -3.7% | +3.6% |
| Dec 2 | Morgan Stanley | Maintains | Overweight → Overweight | — | $74.07 | $74.60 | +0.7% | -0.1% | +1.3% | +1.9% | +0.4% | +0.5% |
| Nov 25 | BTIG | Maintains | Buy → Buy | — | $76.06 | $76.01 | -0.1% | +1.0% | +0.5% | +0.9% | -5.0% | -0.1% |
| Nov 11 | Morgan Stanley | Maintains | Overweight → Overweight | — | $71.78 | $71.60 | -0.3% | -0.3% | -0.6% | -4.4% | +0.8% | -3.1% |
| Nov 11 | Piper Sandler | Maintains | Neutral → Neutral | — | $71.78 | $71.60 | -0.3% | -0.3% | -0.6% | -4.4% | +0.8% | -3.1% |
| Nov 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $72.09 | $71.35 | -1.0% | -0.7% | +0.3% | -0.3% | -0.6% | -4.4% |
| Nov 5 | Canaccord Genuity | Maintains | Buy → Buy | — | $84.49 | $82.23 | -2.7% | -2.6% | -12.4% | -0.7% | +0.3% | -0.3% |
| Nov 5 | Needham | Maintains | Buy → Buy | — | $84.49 | $82.23 | -2.7% | -2.6% | -12.4% | -0.7% | +0.3% | -0.3% |
| Nov 5 | BTIG | Maintains | Buy → Buy | — | $84.49 | $82.23 | -2.7% | -2.6% | -12.4% | -0.7% | +0.3% | -0.3% |
| Oct 22 | Piper Sandler | Maintains | Neutral → Neutral | — | $89.10 | $90.60 | +1.7% | -4.3% | +2.1% | +2.5% | +2.6% | -5.4% |
| Oct 22 | BTIG | Maintains | Buy → Buy | — | $89.10 | $90.60 | +1.7% | -4.3% | +2.1% | +2.5% | +2.6% | -5.4% |
| Sep 26 | Guggenheim | Maintains | Buy → Buy | — | $77.33 | $78.71 | +1.8% | +1.5% | +0.1% | +2.7% | +9.0% | +1.5% |
| Sep 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $88.78 | $89.26 | +0.5% | -2.7% | -1.4% | +2.2% | -0.7% | +0.7% |
| Aug 20 | BTIG | Maintains | Buy → Buy | — | $73.08 | $70.77 | -3.2% | +0.3% | +4.7% | +5.0% | -5.7% | +0.5% |
| Aug 12 | Morgan Stanley | Maintains | Overweight → Overweight | — | $60.82 | $61.35 | +0.9% | +9.1% | +5.0% | +2.8% | +3.1% | +6.3% |
| Jul 29 | BTIG | Maintains | Buy → Buy | — | $62.00 | $61.05 | -1.5% | -6.0% | -0.8% | -2.1% | -3.0% | +4.8% |
| Jun 30 | Guggenheim | Maintains | Buy → Buy | — | $66.52 | $65.69 | -1.2% | -4.5% | -6.4% | -0.5% | +3.0% | -4.9% |
| Jun 25 | BofA Securities | Maintains | Neutral → Neutral | — | $68.28 | $69.58 | +1.9% | -4.1% | +4.4% | -2.7% | -4.5% | -6.4% |
| May 15 | Piper Sandler | Maintains | Neutral → Neutral | — | $64.78 | $64.80 | +0.0% | -3.4% | +4.6% | -2.7% | -2.1% | -6.9% |
| May 9 | Morgan Stanley | Maintains | Overweight → Overweight | — | $65.22 | $66.26 | +1.6% | -5.9% | +2.2% | +9.9% | -6.0% | -3.4% |
| May 7 | Needham | Maintains | Buy → Buy | — | $52.19 | $52.13 | -0.1% | +12.6% | +11.0% | -5.9% | +2.2% | +9.9% |
| Apr 24 | Needham | Maintains | Buy → Buy | — | $49.55 | $50.40 | +1.7% | +8.0% | -1.1% | +1.6% | +1.0% | -4.8% |
| Apr 10 | Needham | Maintains | Buy → Buy | — | $43.79 | $42.85 | -2.1% | -8.0% | +4.5% | +2.4% | -0.5% | -4.8% |
| Mar 6 | Morgan Stanley | Maintains | Overweight → Overweight | — | $53.06 | $50.47 | -4.9% | -7.9% | +0.5% | -8.0% | +0.9% | -0.2% |
| Mar 4 | Piper Sandler | Maintains | Neutral → Neutral | — | $50.93 | $48.59 | -4.6% | +3.5% | +0.6% | -7.9% | +0.5% | -8.0% |
| Mar 3 | BofA Securities | Maintains | Neutral → Neutral | — | $56.18 | $57.55 | +2.4% | -9.3% | +3.5% | +0.6% | -7.9% | +0.5% |
| Feb 25 | JP Morgan | Downgrade | Overweight → Neutral | — | $69.57 | $58.49 | -15.9% | -15.0% | +5.3% | -11.2% | +1.6% | -9.3% |
| Feb 25 | Needham | Maintains | Buy → Buy | — | $69.57 | $58.49 | -15.9% | -15.0% | +5.3% | -11.2% | +1.6% | -9.3% |
| Feb 25 | Guggenheim | Maintains | Buy → Buy | — | $69.57 | $58.49 | -15.9% | -15.0% | +5.3% | -11.2% | +1.6% | -9.3% |
| Feb 12 | William Blair | Downgrade | Outperform → Market Perform | — | $71.21 | $68.43 | -3.9% | +3.7% | +13.4% | +6.8% | -8.4% | +4.6% |
| Jan 14 | Needham | Maintains | Buy → Buy | — | $32.34 | $33.10 | +2.4% | -1.6% | +9.7% | -0.5% | +1.2% | +35.5% |
| Jan 14 | Loop Capital | Maintains | Buy → Buy | — | $32.34 | $33.10 | +2.4% | -1.6% | +9.7% | -0.5% | +1.2% | +35.5% |
| Dec 13 | BofA Securities | Maintains | Neutral → Neutral | — | $41.99 | $42.00 | +0.0% | -2.4% | -2.7% | -2.3% | -11.9% | -3.7% |
| Nov 12 | Piper Sandler | Maintains | Neutral → Neutral | — | $77.62 | $76.20 | -1.8% | -12.3% | +0.1% | -16.8% | -7.5% | +3.2% |
| Nov 11 | Stifel | Downgrade | Buy → Hold | — | $73.77 | $69.78 | -5.4% | +5.2% | -12.3% | +0.1% | -16.8% | -7.5% |
| Oct 15 | Loop Capital | Maintains | Buy → Buy | — | $50.72 | $50.72 | +0.0% | -8.1% | +5.2% | -2.1% | +2.8% | -1.3% |
| Oct 2 | BofA Securities | Downgrade | Buy → Neutral | — | $53.07 | $52.50 | -1.1% | -3.4% | -4.5% | +8.1% | -4.5% | -4.9% |
| Aug 7 | Needham | Maintains | Buy → Buy | — | $40.65 | $39.91 | -1.8% | -4.5% | +0.3% | -0.5% | -0.2% | +10.3% |
| Aug 7 | JP Morgan | Maintains | Overweight → Overweight | — | $40.65 | $39.91 | -1.8% | -4.5% | +0.3% | -0.5% | -0.2% | +10.3% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | LEFKOFSKY ERIC P | CEO and Chairman | Sell | 27,570 | $51.52 | $1.4M | 15,656,469 | -0.87% | -7.53% |
| Apr 28, 2026 | LEFKOFSKY ERIC P | CEO and Chairman | Sell | 105,430 | $51.03 | $5.4M | 15,684,039 | -0.87% | -7.53% |
| Apr 28, 2026 | LEFKOFSKY ERIC P | CEO and Chairman | Sell | 6,890 | $51.52 | $355K | 8,841,783 | -0.87% | -7.53% |
| Apr 28, 2026 | LEFKOFSKY ERIC P | CEO and Chairman | Sell | 26,360 | $51.03 | $1.3M | 8,848,673 | -0.87% | -7.53% |
Data updated apr 27, 2026 4:26am
· Source: massive.com